179 related articles for article (PubMed ID: 36519025)
1. Multi-omics consensus portfolio to refine the classification of lung adenocarcinoma with prognostic stratification, tumor microenvironment, and unique sensitivity to first-line therapies.
Zou Y; Cao C; Wang Y; Zhou Y; Yao S; Zhang L; Zheng K; Zhang H; Qin W; Qin K; Xiong H; Yuan X; Fu S; Wang Y; Xiong H
Transl Lung Cancer Res; 2022 Nov; 11(11):2243-2260. PubMed ID: 36519025
[TBL] [Abstract][Full Text] [Related]
2. Multi-Omics Integrative Analysis of Lung Adenocarcinoma: An
Ruan X; Ye Y; Cheng W; Xu L; Huang M; Chen Y; Zhu J; Lu X; Yan F
Front Med (Lausanne); 2022; 9():894338. PubMed ID: 35721082
[TBL] [Abstract][Full Text] [Related]
3. Molecular classification reveals the diverse genetic and prognostic features of gastric cancer: A multi-omics consensus ensemble clustering.
Hu X; Wang Z; Wang Q; Chen K; Han Q; Bai S; Du J; Chen W
Biomed Pharmacother; 2021 Dec; 144():112222. PubMed ID: 34607103
[TBL] [Abstract][Full Text] [Related]
4. Pan-cancer analysis of UBE2T with a focus on prognostic and immunological roles in lung adenocarcinoma.
Cao K; Ling X; Jiang X; Ma J; Zhu J
Respir Res; 2022 Nov; 23(1):306. PubMed ID: 36357897
[TBL] [Abstract][Full Text] [Related]
5. [Construction and Validation of Prognostic Risk Score Model of Autophagy Related Genes in Lung Adenocarcinoma].
Zhou J; Wang X; Li Z; Jiang R
Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):557-566. PubMed ID: 34256900
[TBL] [Abstract][Full Text] [Related]
6. Molecular cluster mining of high-grade serous ovarian cancer via multi-omics data analysis aids precise medicine.
Cai D; Liu T; Fang J; Liu Y
J Cancer Res Clin Oncol; 2023 Sep; 149(11):9151-9165. PubMed ID: 37178426
[TBL] [Abstract][Full Text] [Related]
7. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
Front Genet; 2022; 13():919389. PubMed ID: 35783281
[No Abstract] [Full Text] [Related]
8. Construction and Validation of a Tumor Microenvironment-Based Scoring System to Evaluate Prognosis and Response to Immune Checkpoint Inhibitor Therapy in Lung Adenocarcinoma Patients.
Huang P; Xu L; Jin M; Li L; Ke Y; Zhang M; Zhang K; Lu K; Huang G
Genes (Basel); 2022 May; 13(6):. PubMed ID: 35741714
[TBL] [Abstract][Full Text] [Related]
9. Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment.
Zhou H; Zheng M; Shi M; Wang J; Huang Z; Zhang H; Zhou Y; Shi J
BMC Cancer; 2021 Aug; 21(1):938. PubMed ID: 34416861
[TBL] [Abstract][Full Text] [Related]
10. Identification and validation of immunotherapy for four novel clusters of colorectal cancer based on the tumor microenvironment.
Zheng X; Ma Y; Bai Y; Huang T; Lv X; Deng J; Wang Z; Lian W; Tong Y; Zhang X; Yue M; Zhang Y; Li L; Peng M
Front Immunol; 2022; 13():984480. PubMed ID: 36389763
[TBL] [Abstract][Full Text] [Related]
11. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
Zuo S; Wei M; Wang S; Dong J; Wei J
Front Immunol; 2020; 11():1218. PubMed ID: 32714316
[No Abstract] [Full Text] [Related]
12. Identification of a Five Autophagy Subtype-Related Gene Expression Pattern for Improving the Prognosis of Lung Adenocarcinoma.
Zhang MY; Huo C; Liu JY; Shi ZE; Zhang WD; Qu JJ; Yue YL; Qu YQ
Front Cell Dev Biol; 2021; 9():756911. PubMed ID: 34869345
[No Abstract] [Full Text] [Related]
13. Molecular subtypes based on cuproptosis-related genes and immune profiles in lung adenocarcinoma.
Wang Y; Zhang C; Ji C; Jin W; He X; Yu S; Guo R
Front Genet; 2022; 13():1006938. PubMed ID: 36313439
[No Abstract] [Full Text] [Related]
14. Histone acetylation modification regulator-mediated tumor microenvironment infiltration characteristics and prognostic model of lung adenocarcinoma patients.
Wang W; Shen Y; Zhang P; Liu L; Sha X; Li H; Wang S; Zhang H; Zhou Y; Shi J
J Thorac Dis; 2022 Oct; 14(10):3886-3902. PubMed ID: 36389327
[TBL] [Abstract][Full Text] [Related]
15. Tumor microenvironment related novel signature predict lung adenocarcinoma survival.
Chen J; Zhou R
PeerJ; 2021; 9():e10628. PubMed ID: 33520448
[TBL] [Abstract][Full Text] [Related]
16. Typical tumor immune microenvironment status determine prognosis in lung adenocarcinoma.
Ren C; Li J; Zhou Y; Zhang S; Wang Q
Transl Oncol; 2022 Apr; 18():101367. PubMed ID: 35176624
[TBL] [Abstract][Full Text] [Related]
17. Clinical Significance and Immunologic Landscape of a Five-IL(R)-Based Signature in Lung Adenocarcinoma.
Fan T; Pan S; Yang S; Hao B; Zhang L; Li D; Geng Q
Front Immunol; 2021; 12():693062. PubMed ID: 34497605
[TBL] [Abstract][Full Text] [Related]
18. Identification of N7-methylguanosine related signature for prognosis and immunotherapy efficacy prediction in lung adenocarcinoma.
Li Z; Wang W; Wu J; Ye X
Front Med (Lausanne); 2022; 9():962972. PubMed ID: 36091687
[TBL] [Abstract][Full Text] [Related]
19. A methylation-related signature for predicting prognosis and sensitivity to first-line therapies in gastric cancer.
Cao C; Luo Z; Zhang H; Yao S; Lu H; Zheng K; Wang Y; Zou M; Qin W; Xiong H; Yuan X; Wang Y; Pinheiro RN; Peixoto RD; Zou Y; Xiong H
J Gastrointest Oncol; 2023 Dec; 14(6):2354-2372. PubMed ID: 38196539
[TBL] [Abstract][Full Text] [Related]
20. Identification of a four-gene panel predicting overall survival for lung adenocarcinoma.
Li C; Long Q; Zhang D; Li J; Zhang X
BMC Cancer; 2020 Dec; 20(1):1198. PubMed ID: 33287749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
